On July 14, Kaldalón announced the purchase of its own shares under a buyback program in week 28. The announcement stated that 2,544,345 of its own shares had been purchased at a purchase price of ISK 61,909,963, as further detailed in the announcement. Kaldalón received corrected information that in that week, Kaldalón purchased 2,549,537 own shares for ISK 62,035,609, as detailed below: Date Time Volume Price Purchae price Own shares post trans. 8.7.2025 10:28:10 635,000 24,2 15.367.000 ...

EAGLE, Idaho, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that on October 1, 2025, it acquired certain operations from UnitedHealth Group Incorporated (“UnitedHealth”). The operations were divested pursuant to UnitedHealth’s and Amedisys Inc.’s (“Amedisys”) antitrust settlement with the United States Justice Department. Pennant is purchasing diveste ...

Company transforms future-ready workspaces and simplifies work experiences with intelligent AI-powered solutionsNews Highlights: Announces 14 innovations to enhance workspaces, AI workflows, remote device support, and smart printing experiences.Introduces new ways to curate and maximize workspace with the latest displays and a dock that features proximity activation.Innovates AI development with the HP ZGX Nano G1n AI Station and new HP ZGX Toolkit.Empowers IT with new features, like Remote Connect, to sec ...

STAFFORD, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the expansion of FLAMINGO-01 clinical trial to Belgium. The Company's application to European regulators has been formally approved, adding Belgium as an approved country in FLAMINGO-01 in addition to S ...

Highlights: US Tariffs: Immuron does not anticipate any material impact from the recently announced US tariffs on pharmaceutical productsTravelan® Clinical Study: Topline results from the Travelan® clinical study conducted by Uniformed Services University are anticipated in October 2025 IMM-529 Regulatory Milestone: Immuron plans to submit an Investigational New Drug (IND) application to the U.S. FDA for IMM-529 (Clostridiodes difficile infection) in mid-October 2025ProIBS® Commercial Launch: The Australian ...

NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity company, today announced the expansion of CLEAR+ enrollment, enabling travelers from 40 countries across Europe, Asia, and the Americas to join CLEAR+ and enjoy a faster, easier, and more seamless travel experience at U.S. airports. The expansion broadens eligibility for CLEAR+ and gives international visitors to the U.S. a much-needed way to reduce stress and simplify their journeys. International visitors can start their CL ...

METTAWA, Ill., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC) will release its 2025 third quarter financial results on Thursday, October 23, 2025 before the market opens by way of an advisory release, notifying the public that the complete and full-text results will be available on the Company’s website at https://ir.brunswick.com. The results will also be available on the SEC’s website with the Form 8-K filing of the release. The Company will hold a conference call at 10 a.m. CT / 11 a. ...

GUANGZHOU, China, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd (“Viomi” or the "Company") (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced that it has received a notification from The Nasdaq Stock Market LLC (“Nasdaq”) on October 1, 2025, confirming that the Company has regained compliance with the periodic filing requirement for Nasdaq under Listing Rule 5250(c)(1). Nasdaq has noted that this matter is now closed. About Viomi Technology Viomi’s ...

Deepti Velury named CEO Publicis Global ProductionAs Group Further Accelerates on Intelligent Creativity October 2nd, 2025 – Paris – Publicis Groupe [Euronext Paris FR0000130577, CAC 40] announces the appointment of Deepti Velury as CEO of Global Production. In this newly created role, Velury will oversee all of the Groupe’s production capabilities, spanning global content studios, proprietary AI technology platforms, including GenAI partnerships and global production hubs. At a time when it's never been ch ...

France Places New Falcon Albatros Order Saint-Cloud, France, October 2, 2025 – On September 26, 2025, the French Defense Procurement and Technology Agency (DGA) placed an order with Dassault Aviation for five Falcon 2000 Albatros aircraft as part of the Maritime Surveillance and Intervention Aircraft (AVSIMAR) program. A total of twelve aircraft are planned under this program, of which seven were previously ordered in December 2020. Dassault Aviation, together with the many French companies contributing to ...